X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (113) 113
index medicus (110) 110
humans (106) 106
male (69) 69
cancer (59) 59
aged (53) 53
middle aged (50) 50
female (47) 47
bladder cancer (46) 46
chemotherapy (45) 45
urology & nephrology (43) 43
aged, 80 and over (35) 35
urology (35) 35
treatment outcome (30) 30
urinary bladder neoplasms - drug therapy (28) 28
urinary bladder neoplasms - pathology (28) 28
abridged index medicus (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
article (25) 25
survival (25) 25
care and treatment (24) 24
radical cystectomy (23) 23
urothelial carcinoma (23) 23
transitional-cell carcinoma (21) 21
adult (19) 19
cystectomy (19) 19
research (19) 19
retrospective studies (19) 19
antineoplastic agents - therapeutic use (18) 18
prognosis (18) 18
urothelial cancer (18) 18
metastasis (17) 17
carcinoma (16) 16
cisplatin (15) 15
neoadjuvant chemotherapy (15) 15
prostate cancer (15) 15
analysis (14) 14
carcinoma, transitional cell - drug therapy (14) 14
urinary bladder neoplasms - therapy (14) 14
cisplatin-based chemotherapy (13) 13
neoplasm invasiveness (13) 13
urinary bladder neoplasms - genetics (13) 13
cisplatin - administration & dosage (12) 12
health aspects (12) 12
phase-ii trial (12) 12
urinary bladder neoplasms - mortality (12) 12
urinary bladder neoplasms - surgery (12) 12
urothelium - pathology (12) 12
drug therapy (11) 11
expression (11) 11
immunotherapy (11) 11
methotrexate (11) 11
neoadjuvant therapy (11) 11
neoplasm staging (11) 11
patient outcomes (11) 11
survival analysis (11) 11
transitional cell carcinoma (11) 11
trial (11) 11
chemotherapy, adjuvant (10) 10
gemcitabine (10) 10
neoplasm metastasis (10) 10
risk factors (10) 10
survival rate (10) 10
usage (10) 10
bladder-cancer (9) 9
breast-cancer (9) 9
carcinoma, transitional cell - pathology (9) 9
diagnosis (9) 9
disease-free survival (9) 9
kidney neoplasms - drug therapy (9) 9
neoadjuvant (9) 9
outcomes (9) 9
therapy (9) 9
tumors (9) 9
adjuvant chemotherapy (8) 8
adjuvant treatment (8) 8
biomarkers (8) 8
deoxycytidine - administration & dosage (8) 8
deoxycytidine - analogs & derivatives (8) 8
drug administration schedule (8) 8
gemcitabine plus cisplatin (8) 8
kidney neoplasms - pathology (8) 8
medical colleges (8) 8
mutation (8) 8
randomized-trial (8) 8
transitional-cell-carcinoma (8) 8
vinblastine (8) 8
antibodies, monoclonal - therapeutic use (7) 7
carcinoma, renal cell - drug therapy (7) 7
doxorubicin (7) 7
doxorubicin - administration & dosage (7) 7
hematology, oncology and palliative medicine (7) 7
invasive bladder-cancer (7) 7
long-term-survival (7) 7
molecular targeted therapy (7) 7
time factors (7) 7
antigens (6) 6
antigens, surface - immunology (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
bladder (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 12/2016, Volume 122, Issue 24, pp. 3893 - 3893
Journal Article
Cancer, ISSN 0008-543X, 03/2016, Volume 122, Issue 5, pp. 676 - 677
Journal Article
Cancer, ISSN 0008-543X, 01/2015, Volume 121, Issue 2, pp. 179 - 187
Journal Article
Cancer, ISSN 0008-543X, 08/2013, Volume 119, Issue 16, pp. 2950 - 2952
Journal Article
Cancer, ISSN 0008-543X, 08/2013, Volume 119, Issue 16, p. 2950
Journal Article
Science, ISSN 0036-8075, 10/2012, Volume 338, Issue 6104, pp. 221 - 221
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 2, pp. 160 - 161
Journal Article
Cancer, ISSN 0008-543X, 07/2016, Volume 122, Issue 13, pp. 2012 - 2020
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 389 - 389
Journal Article
Cancer, ISSN 0008-543X, 7/2016, Volume 122, Issue 13, pp. 2012 - 2020
Journal Article
Journal Article
ONCOLOGY (United States), ISSN 0890-9091, 2013, Volume 27, Issue 3, pp. 233 - C3
  Novel agents targeting HER2/new have changed the landscape in the management of women with breast cancer. More recently, a phase III trial of trastuzumab... 
Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Urinary Bladder Neoplasms - drug therapy | Molecular Targeted Therapy | Humans | Carcinoma, Transitional Cell - drug therapy | Chemotherapy | Research | Diagnosis | Drug therapy | Health aspects | Urinary tract cancer | Cancer | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.